• Home
  • Contact Us
  • Try it!
  • Blog
  • Vizit Graphs

Follow us

Recent Posts

  • Biovista in World’s Top 20 AI Drug Development Companies March 22, 2019
  • Biovista signs EU-IMI2 research agreement to advance neurotoxicity de-risking in preclinical drug discovery March 15, 2019
  • The increasing importance of predicting AEs & the role of Augmented Intelligence September 10, 2018
  • New Vizit Bibliography pane January 8, 2018
  • Share to Weibo added to Biovista Vizit October 25, 2017

Biovista Vizit

Biovista Vizit

  • Try it!
  • Blog
  • Vizit Graphs

DIHYDROXYPHENYLALANINE

Drugs for Parkinson’s and Alzheimer’s

August 27, 2018Alzheimer's, Nervous System Disorders, Parkinson's, Vizit Graphs
Drugs for Parkinson’s and Alzheimer’s

Find drugs common to both Parkinson’s and Alzheimer’s diseases using Biovista Vizit. Explore the live graph.

Parkinson’s disease and Diabetes Type 2

August 27, 2018Diabetes, Metabolic Disorders, Nervous System Disorders, Parkinson's, Vizit Graphs
Parkinson disease and Diabetes Type 2

Incretin mimetics or GLP-1 receptor agonists are commonly used in Type 2 Diabetes. Recent evidence favors their use for the treatment of Parkinson’s disease. Explore the live graph.

Vizit Graphs Tag Cloud

FOXP3 ALZHEIMER'S DISEASE HELICOBACTER PYLORI CELL PROLIFERATION DOXORUBICIN PORPHYROMONAS GINGIVALIS CD4 TH17 CELLS BREAST CANCER AGING STREPTOCOCCUS PNEUMONIAE ERBB-2 SOD1 IMMUNE RESPONSE IL23A RECEPTOR 1-METHYL-4-PHENYL-1-2-3-6-TETRAHYDROPYRIDINE IL17A APOPTOTIC PROCESS TNF METFORMIN IL6 CTLA4 IFNG CASP3 INFLAMMATION CANCER REMICADE CELL DEATH DIABETES MELLITUS PARKINSON DISEASE AUTOPHAGY CELL DIVISION INSULIN STAPHYLOCOCCUS AUREUS CELL DIFFERENTIATION CANDIDA ALBICANS TP53 RHEUMATOID ARTHRITIS NEURODEGENERATIVE DISORDERS PSEUDOMONAS AERUGINOSA ANGIOGENESIS CLOSTRIDIUM DIFFICILE ESCHERICHIA COLI LISTERIA MONOCYTOGENES

© 2019 Biovista Vizit All Rights Reserved.